Activators of TCEAL4 facilitate its role in transcriptional regulation by modulating the signaling pathways and cellular processes that govern its activity. For instance, certain activators work by increasing intracellular levels of second messengers, such as cyclic AMP, which in turn activate protein kinases like PKA. The phosphorylation cascade that follows can lead to the phosphorylation of transcription factors and coactivators that are part of the transcription machinery, thereby enhancing the activity of TCEAL4. Similarly, other activators directly target protein kinases such as PKC to enhance the phosphorylation of proteins that interact with transcription elongation factors, potentially affecting TCEAL4's function in this process. Moreover, the role of TCEAL4 is also influenced by changes in chromatin structure, where compounds that inhibit histone deacetylases can remodel chromatin to increase TCEAL4's access to DNA and augment its activity in transcription elongation.
Additional mechanisms by which these activators influence TCEAL4 involve altering intracellular calcium concentrations, which can modulate the activity of transcription factors and coactivators within relevant signaling pathways. Ionophores increase the cytosolic calcium levels, thereby potentially affecting the activity of transcriptional regulators in pathways that TCEAL4 is a part of. Other activators include polyphenols and compounds from natural sources that are known to modulate various signal transduction pathways, which may in turn influence the transcriptional regulatory functions where TCEAL4 is implicated.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Adenylyl cyclase activator that increases cyclic AMP levels, enhancing PKA activity which can phosphorylate transcription factors and coactivators associated with the transcription machinery, potentially increasing TCEAL4 activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activator of Protein Kinase C (PKC) which may enhance the phosphorylation of proteins involved in transcription elongation, affecting TCEAL4's function. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Modulates signal transduction pathways, potentially enhancing TCEAL4's role in transcriptional regulation. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
Analog of cyclic AMP that activates PKA, possibly influencing the phosphorylation state of transcriptional machinery to which TCEAL4 contributes. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Histone deacetylase inhibitor that can alter chromatin structure, potentially enhancing access of TCEAL4 to DNA and increasing its activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Calcium ionophore that increases intracellular calcium concentrations, potentially modulating transcription factors and coactivators in pathways where TCEAL4 is involved. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Beta-adrenergic agonist that increases cyclic AMP levels, possibly leading to enhanced PKA activity and subsequent activation of transcriptional processes involving TCEAL4. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor that can lead to changes in chromatin architecture, potentially facilitating TCEAL4-mediated transcription. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Phosphodiesterase inhibitor that prevents the breakdown of cyclic AMP, potentially enhancing PKA-mediated transcription processes where TCEAL4 is involved. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-specific inhibitor of cyclic AMP and cyclic GMP phosphodiesterases, possibly leading to increased PKA activity and TCEAL4-mediated transcription. | ||||||